Chemistry:Tiapamil

From HandWiki
Short description: Chemical compound
Tiapamil
Dimeditiapramine.svg
Dimeditiapramine 3D spacefill.png
Clinical data
Other namesDimeditiapramine; Ro 11-1781
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC26H37NO8S2
Molar mass555.70 g·mol−1
3D model (JSmol)

Tiapamil (INN; also known as dimeditiapramine) is a calcium antagonist or calcium channel blocker.[1][2] It is an experimental drug that has never been marketed.[3]

Tiapamil has been described as an antianginal agent. It exhibits properties of anti-arrhythmic medications. These are medications that are used to treat unusually fast or irregular heartbeats. Examples of arrhytmthic conditions include atrial fibrillation, atrial flutter, and super-ventricular tachycardia.[4] Upon research, the drug shows promising effects on treatment of these condition. Research seeks to create a treatment with tiapamil in order to mitigate the side effects of the more commonly prescribed calcium antagonist and anti-hypertensive verapamil. The two drugs have similar properties; however, tiapamil appears to treat arrhythmic conditions without many of the hypotensive, negative inotropic, and negative chronotropic side effects. Tiapamil is a calcium channel blocker that acts on the slow calcium channels. It can treat ventricular arrhythmias to a higher degree than traditional calcium antagonists.

See also

References

  1. "Human electropharmacology of the calcium antagonist dimeditiapramine (Ro 11-1781) in coronary patients". Clinical Cardiology 2 (3): 212–216. June 1979. doi:10.1002/clc.4960020307. PMID 509799. 
  2. "Antiarrhythmic effect of the calcium antagonist tiapamil (Ro 11-1781) by intravenous administration in patients with coronary heart disease". Clinical Cardiology 3 (6): 371–376. December 1980. doi:10.1002/clc.4960030603. PMID 6161729. 
  3. "Tiapamil". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800028673. 
  4. "Dimeditiapramine (Ro 11-1781), a new calcium antagonist, in the management of supraventricular tachyarrhythmias in patients with acute myocardial infarction". Clinical Cardiology 2 (2): 131–134. April 1979. doi:10.1002/clc.4960020208. PMID 262567.